Guidelines for time-to-event end point definitions in breast cancer trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials)

S. Gourgou-bourgade; D. Cameron; P. Poortmans; B. Asselain; D. Azria; F. Cardoso; R. A'hern; J. Bliss; J. Bogaerts; H. Bonnefoi; E. Brain; M. J. Cardoso; B. Chibaudel; R. Coleman; T. Cufer; L. Dal Lago; F. Dalenc; E. De Azambuja; M. Debled; S. Delaloge; T. Filleron; J. Gligorov; M. Gutowski; W. Jacot; C. Kirkove; G. Macgrogan; S. Michiels; I. Negreiros; B. V. Offersen; F. Penault Llorca; G. Pruneri; H. Roche; N. S. Russell; F. Schmitt; V. Servent; B. Thurlimann; M. Untch; J. A. Van Der Hage; G. Van Tienhoven; H. Wildiers; J. Yarnold; F. Bonnetain; S. Mathoulin-pelissier; C. Bellera; T. S. Dabakuyo-yonli

doi:10.1093/annonc/mdv106

Guidelines for time-to-event end point definitions in breast cancer trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials)

S. Gourgou-bourgade, D. Cameron, P. Poortmans, B. Asselain, D. Azria, F. Cardoso, R. A'hern, J. Bliss, J. Bogaerts, H. Bonnefoi, E. Brain, M. J. Cardoso, B. Chibaudel, R. Coleman, T. Cufer, L. Dal Lago, F. Dalenc, E. De Azambuja, M. Debled, S. DelalogeT. Filleron, J. Gligorov, M. Gutowski, W. Jacot, C. Kirkove, G. Macgrogan, S. Michiels, I. Negreiros, B. V. Offersen, F. Penault Llorca, G. Pruneri, H. Roche, N. S. Russell, F. Schmitt, V. Servent, B. Thurlimann, M. Untch, J. A. Van Der Hage, G. Van Tienhoven, H. Wildiers, J. Yarnold, F. Bonnetain, S. Mathoulin-pelissier, C. Bellera, T. S. Dabakuyo-yonli

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	873-879
Journal	Annals of Oncology
Volume	26
Issue number	5
DOIs	https://doi.org/10.1093/annonc/mdv106
Publication status	Published - 1 May 2015

Access to Document

10.1093/annonc/mdv106

http://annonc.oxfordjournals.org/cgi/doi/10.1093/annonc/mdv106

Cite this

Gourgou-bourgade, S., Cameron, D., Poortmans, P., Asselain, B., Azria, D., Cardoso, F., A'hern, R., Bliss, J., Bogaerts, J., Bonnefoi, H., Brain, E., Cardoso, M. J., Chibaudel, B., Coleman, R., Cufer, T., Dal Lago, L., Dalenc, F., De Azambuja, E., Debled, M., ... Dabakuyo-yonli, T. S. (2015). Guidelines for time-to-event end point definitions in breast cancer trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials). Annals of Oncology, 26(5), 873-879. https://doi.org/10.1093/annonc/mdv106

@article{4afdce3811814bf7bc46884babd6fe29,

title = "Guidelines for time-to-event end point definitions in breast cancer trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials)",

author = "S. Gourgou-bourgade and D. Cameron and P. Poortmans and B. Asselain and D. Azria and F. Cardoso and R. A'hern and J. Bliss and J. Bogaerts and H. Bonnefoi and E. Brain and Cardoso, {M. J.} and B. Chibaudel and R. Coleman and T. Cufer and {Dal Lago}, L. and F. Dalenc and {De Azambuja}, E. and M. Debled and S. Delaloge and T. Filleron and J. Gligorov and M. Gutowski and W. Jacot and C. Kirkove and G. Macgrogan and S. Michiels and I. Negreiros and Offersen, {B. V.} and {Penault Llorca}, F. and G. Pruneri and H. Roche and Russell, {N. S.} and F. Schmitt and V. Servent and B. Thurlimann and M. Untch and {Van Der Hage}, {J. A.} and {Van Tienhoven}, G. and H. Wildiers and J. Yarnold and F. Bonnetain and S. Mathoulin-pelissier and C. Bellera and Dabakuyo-yonli, {T. S.}",

note = "16/2/2015 This work was presented as a poster communication at the following meetings: ASCO(Chicago, June 2013), ECCO/ESMO (Amsterdam, September 2013), and SABCS (San Antonio Breast Cancer Symposium, San Antonio, December 2013).",

year = "2015",

month = may,

day = "1",

doi = "10.1093/annonc/mdv106",

language = "English",

volume = "26",

pages = "873--879",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Elsevier",

number = "5",

}

Gourgou-bourgade, S, Cameron, D, Poortmans, P, Asselain, B, Azria, D, Cardoso, F, A'hern, R, Bliss, J, Bogaerts, J, Bonnefoi, H, Brain, E, Cardoso, MJ, Chibaudel, B, Coleman, R, Cufer, T, Dal Lago, L, Dalenc, F, De Azambuja, E, Debled, M, Delaloge, S, Filleron, T, Gligorov, J, Gutowski, M, Jacot, W, Kirkove, C, Macgrogan, G, Michiels, S, Negreiros, I, Offersen, BV, Penault Llorca, F, Pruneri, G, Roche, H, Russell, NS, Schmitt, F, Servent, V, Thurlimann, B, Untch, M, Van Der Hage, JA, Van Tienhoven, G, Wildiers, H, Yarnold, J, Bonnetain, F, Mathoulin-pelissier, S, Bellera, C & Dabakuyo-yonli, TS 2015, 'Guidelines for time-to-event end point definitions in breast cancer trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials)', Annals of Oncology, vol. 26, no. 5, pp. 873-879. https://doi.org/10.1093/annonc/mdv106

Guidelines for time-to-event end point definitions in breast cancer trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials). / Gourgou-bourgade, S.; Cameron, D.; Poortmans, P. et al.
In: Annals of Oncology, Vol. 26, No. 5, 01.05.2015, p. 873-879.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - Guidelines for time-to-event end point definitions in breast cancer trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials)

AU - Gourgou-bourgade, S.

AU - Cameron, D.

AU - Poortmans, P.

AU - Asselain, B.

AU - Azria, D.

AU - Cardoso, F.

AU - A'hern, R.

AU - Bliss, J.

AU - Bogaerts, J.

AU - Bonnefoi, H.

AU - Brain, E.

AU - Cardoso, M. J.

AU - Chibaudel, B.

AU - Coleman, R.

AU - Cufer, T.

AU - Dal Lago, L.

AU - Dalenc, F.

AU - De Azambuja, E.

AU - Debled, M.

AU - Delaloge, S.

AU - Filleron, T.

AU - Gligorov, J.

AU - Gutowski, M.

AU - Jacot, W.

AU - Kirkove, C.

AU - Macgrogan, G.

AU - Michiels, S.

AU - Negreiros, I.

AU - Offersen, B. V.

AU - Penault Llorca, F.

AU - Pruneri, G.

AU - Roche, H.

AU - Russell, N. S.

AU - Schmitt, F.

AU - Servent, V.

AU - Thurlimann, B.

AU - Untch, M.

AU - Van Der Hage, J. A.

AU - Van Tienhoven, G.

AU - Wildiers, H.

AU - Yarnold, J.

AU - Bonnetain, F.

AU - Mathoulin-pelissier, S.

AU - Bellera, C.

AU - Dabakuyo-yonli, T. S.

N1 - 16/2/2015 This work was presented as a poster communication at the following meetings: ASCO(Chicago, June 2013), ECCO/ESMO (Amsterdam, September 2013), and SABCS (San Antonio Breast Cancer Symposium, San Antonio, December 2013).

PY - 2015/5/1

Y1 - 2015/5/1

U2 - 10.1093/annonc/mdv106

DO - 10.1093/annonc/mdv106

M3 - Article

SN - 0923-7534

VL - 26

SP - 873

EP - 879

JO - Annals of Oncology

JF - Annals of Oncology

IS - 5

ER -